CFA
IDXX icon

Camarda Financial Advisors’s Idexx Laboratories IDXX Stock Holding History

Camarda Financial Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,098
Closed -$3.26M – 111
2025
Q3 		$3.26M Buy
5,098
+466
+10% +$283K 1.2% 22
2025
Q2 		$2.48M Buy
+4,632
New +$2.21M 0.98% 31

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Camarda Financial Advisors's IDXX Position: Q4 2025 in Review

Camarda Financial Advisors sold out of Idexx Laboratories (IDXX) in Q4 2025, closing a stake of 5,098 shares — an estimated $3.26M sold.

Camarda Financial Advisors first reported a position in IDXX in Q2 2025 and held it in 2 quarters. The position peaked at $3.26M in Q3 2025. 1,385 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

  • Camarda Financial Advisors reported no remaining Idexx Laboratories position as of Q4 2025 after selling out during the quarter.
  • Camarda Financial Advisors sold 5,098 Idexx Laboratories shares in Q4 2025, an estimated $3.26M.
  • Camarda Financial Advisors first reported a position in Idexx Laboratories in Q2 2025 and held it in 2 quarters.
  • Camarda Financial Advisors's Idexx Laboratories position peaked at $3.26M in Q3 2025.
  • 1,385 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on Camarda Financial Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.